Rhodanineacetic acid derivatives as potential drugs: Preparation, hydrophobic properties and antifungal activity of (5-arylalkylidene-4-oxo-2- thioxo-1,3-thiazolidin-3-yl)acetic acids

Molecules

Volumn 14, Issue 10, 2009, Pages 4197-4212

  Dolezel, Jan ^a   Hirsova, Petra ^a   Opletalova, Veronika ^a   Dohnal, Jiri ^b,c   Marcela, Vejsova ^d   Kunes, Jiri ^a   Jampilek, Josef ^b,c  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b Zentiva Prague   (Czech Republic)

^c UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

(5Z) (5 arylalkylidene 4 oxo 2 thioxo 1,3 thiazolidin 3 yl) acetic acids; In vitro antifungal activity; Lipophilicity measurement; Synthesis

Indexed keywords

ACETIC ACID DERIVATIVE; ANTIFUNGAL AGENT; DRUG DERIVATIVE; EPALRESTAT; RHODANINE; THIAZOLIDINE DERIVATIVE;

ARTICLE; CANDIDA GLABRATA; CANDIDA TROPICALIS; CHEMISTRY; DRUG EFFECT; SYNTHESIS; TRICHOSPORON;

ACETIC ACIDS; ANTIFUNGAL AGENTS; CANDIDA GLABRATA; CANDIDA TROPICALIS; RHODANINE; THIAZOLIDINES; TRICHOSPORON;

EID: 70350500264     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14104197     Document Type: Article

References (64)

1. Boyd, D.B. On the rhodanines and their presence in biologically active ligands. J. Mol. Struct. Theochem. 1997, 401, 227-234.
2. Körner, H. Derivatives of dithiocarbaminoacetic acid. Ber. Dtsch. Chem. Ges. 1908, 41, 1901-1905; [Chem. Abstr. 1908, 2, 12300].
3. Andreasch, R. Substituted rhodaninic acids and their aldehyde condensation products. VII. Monatsh. Chem. 1908, 29, 399-419; [Chem. Abstr. 1908, 2, 14948].
4. Taniyama, H.; Yasui, B.; Takehara, N.; Uchida, H. Chemotherapeutics for Mycobacterium tuberculosis. XIX. Synthesis and antibacterial activity of some 3-substituted rhodanines. Yakugaku Zasshi 1959, 79, 1465-1468; [Chem. Abstr. 1960, 54, 34220].
5. Singh, J.; Nathan, C.F.; Bryk, R.; Samy, R.; Pupek, K.; Gurney, M. Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosis. WO Pat. 2008005651, 2008.
6. Allan, F.J.; Allan, G.G.; Crank, G.; Jack, J. The condensation of rhodanine and derivatives with benzaldehyde sulphonic acids. Recl. Trav. Chim. Pays Bas 1960, 79, 247-254.
7. Allan, F.J.; Allan, G.G. The condensation of rhodanine and derivatives with 4-antipyrinaldehyde. Can. J. Chem. 1961, 39, 1397-1399.
8. Allan, F.J.; Allan, G.G.; Thompson, J.B. The condensation of rhodanine and derivatives with pyridine and quinoline aldehydes. Recl. Trav. Chim. Pays Bas 1961, 80, 403-408.
9. Allan, F.J.; Allan, G.G. The condensation of rhodanine and derivatives with some indole aldehydes. Monatsh. Chem. 1963, 94, 1434-4475; [Chem. Abstr. 1963, 59, 48312].
10. Allan, F.J.; Allan, G.G. The condensation of rhodanine and derivatives with aromatic aldehydes containing iodine. Recl. Trav. Chim. Pays Bas 1962, 82, 177-181.
11. Allan, F.J.; Allan, G.G. Izoxazolylmethylenerhodanines. Recl. Trav. Chim. Pays Bas 1964, 83, 1299-1300.
12. Orchard, M.G.; Neuss, J.C.; Galley, C.M.S. Benzylidene thiazolidinediones and their use as antimycotic agents. WO Pat. 02017915, 2002.
13. Orchard, M.G.; Neuss, J.D. Preparation of thiazolidines as antifungal agents. WO Pat. 0222612, 2002.
14. Orchard, M.G. Preparation of 5-benzylidene-4-thiazolidinone-2-thione antifungal agents. WO Pat. 03070238, 2003.
15. Orchard, M.G.; Neuss, J.C.; Galley, C.M.S.; Carr, A.; Porter, D.W.; Smith, P.; Scopes, D.I.C.; Haydon, D.; Vousden, K.; Stubberfield, C.R.; Young, K.; Page, M. Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT 1). Bioorg. Med. Chem. Lett. 2004, 14, 3975-3978.
16. Dovlatyan, V.V.; Avetisyan, F.V. 2-Thioxo-4-imino(oxo)-1,3-thiazolidin-3- ylacetic acid and its alkyl esters. Armyanskii Khim. Zh. 1973, 26, 494-498; [Chem. Abstr. 1973, 79, 115482].
17. Inamori, Y.; Muro, C.; Tanaka, R.; Adachi, A.; Miyamoto, K.; Tsujibo, H. Phytogrowthinhibitory activity of sulfur-containing compounds. I. Inhibitory activities of thiazolidine derivatives on plant growth. Chem. Pharm. Bull. 1992, 40, 2854-2856.
18. Muro, C.; Yasuda, M.; Sakagami, Y.; Yamada, T.; Tsujibo, H.; Numata, A.; Inamori, Y. Inhibitory activities of rhodanine derivatives on plant growth. Biocsi. Biotechnol. Biochem. 1996, 60, 1368-1371.
19. Frankov, I.A.; Kirillov, M.V.; Sokolova, T.N.; Skupskaya, R.; Kharitonovich, A.N.; Chizhevskaya, I.I. Synthesis and pharmacological properties of alkyl derivatives of 3-carboxyalkylrhodanine. Khim.-Farm. Zh. 1985, 19, 943-946; [Chem. Abstr. 1986, 104, 129831].
20. Friebe, W.G.; Krell, H.W.; Woelle, S.; Wolff, H.P. Thiazolidine carboxylic acid derivatives and their use in the treatment of cancer. WO Pat. 0157006, 2001.
21. Singh, R.; Ramesh, U.V.; Goff, D.; Laidig, G.; Issakani, S.D.; Huang, J.; Payan, D.G.; Clough, J. Rhodanine derivatives and pharmaceutical compositions containing them. WO Pat. 2004043955, 2004.
22. Esswein, A.; Schaefer, W.; Tsaklakidis, C.; Honold, K.; Kaluza, K. Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders. US Pat. App. 2003032813, 2003.
23. Esswein, A.; Schaefer, W.; Tsaklakidis, C.; Honold, K.; Kaluza, K. Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders. US Pat. App. 6673816, 2004.
24. Smith, T.J.; Young, B.L.; Denton, H.; Hughes, D.L.; Wagner, G.W. First small molecular inhibitors of T. brucei dolicholphospate mannose synthase (DPMS), a validated target in African sleeping sickness. Bioorg. Med. Chem. Lett. 2009, 19, 1749-1752.
25. Ziegler, D. Treatment of diabetic neuropathy and neuropathic pain: how far have we come? Diabetes Care 2008, 31 (Suppl. 2), S255-S261.
26. Ramirez, M.A.; Borja, N.L. Epalrestat: An aldose reductase inhibitor for the treatment of diabetic neuropathy. Pharmacotherapy 2008, 28, 646-655.
27. Tanaouchi, T.; Kawamura, M.; Ajima, A.; Mohri, T.; Hayashi, M.; Terashima, H.; Hirata, F.; Morimura, T. Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient. EP Pat. 0047109, 1982.
28. Tanaouchi, T.; Kawamura, M.; Ajima, A.; Mohri, T.; Hayashi, M.; Terashima, H.; Hirata, F.; Morimura, T. Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient. US Pat. 4464382, 1984.
29. Tomasic, T.; Masic, L.P. Rhodanine as a privileged scaffold in drug discovery. Curr. Med. Chem. 2009, 16, 1596-1629.
30. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 1997, 23, 3-25.
31. Avdeef, A. Physicochemical profiling (permeability, solubility, charge state). Curr. Topics Med. Chem. 2001, 1, 277-351.
32. Pliska, V. Lipophilicity in drug action and toxicology. In Methods and Principles in Medicinal Chemistry, 1st ed.; Pliska, V., Testa, B., van der Waterbeemd, H., Eds.; Wiley-VCH: Weinheim, Germany, 1996; Vol. 4, pp. 1-6.
33. Gocan, S.; Cimpan, G.; Comer, J. Lipophilicity measurements by liquid chromatography. Adv. Chromatogr. 2006, 44, 79-176.
34. Opletalova, V.; Dolezal, M.; Hartl, J. Oxidation of hydroxymethylpyrazine using sonication. In Book of Abstracts of the 23rd Conference Drug Synthesis and Analysis; In the 23rd Conference Drug Synthesis and Analysis, Bratislava, Slovakia, October 4-10, 1994; p. 25.
35. Opletalova, V.; Patel, A.; Boulton, M.; Dundrova, A.; Lacinova, E.; Prevorova, M.; Appeltauerova, M.; Coufalova, M. 5-Alkyl-2-pyrazinecarboxamides, 5-alkyl-2-pyrazinecarbonitriles and 5-alkyl-2-acetylpyrazines as synthetic intermediates for antiinflammatory agents. Collect. Czech Chem. Commun. 1996, 61, 1093-1101.
36. Opletalova, V.; Jampilek, J.; Chlupacova, M.; Dolezel, J.; Dohnal, J. Chromatographic and computational study of hydrophobic properties of ring substituted pyrazinecarbonitriles and acetylpyrazines. In Proceedings of the 9th International Electronic Conference on Synthetic Organic Chemistry (ECSOC-9), November 1-30, 2005 [CD-ROM ed.]; Seijas, J.A., Tato, M.P. V., Eds.; MDPI: Basel, Switzerland, 2005; c004.
37. Jampilek, J.; Opletalova, V.; Grafnetterova, T.; Dohnal, J. Thiosemicarbazones of acetylpyrazines: preparation and their hydrophobic properties. In Proceedings of the 9th International Electronic Conference on Synthetic Organic Chemistry (ECSOC-9), November 1- 30, 2005 [CD-ROM ed.]; Seijas, J.A., Tato, M.P.V., Eds.; MDPI: Basel, Switzerland, 2005; a001.
38. Jampilek, J.; Opletalova, V.; Dohnal, J. N,N-Dimethylthiosemicarbazones of acetylpyrazines: Preparation and their hydrophobic properties. In Proceedings of the 10th International Electronic Conference on Synthetic Organic Chemistry (ECSOC-10), November 1-30, 2006 [CD-ROM ed.]; Seijas, J. A., Tato, M. P. V., Eds.; MDPI: Basel, Switzerland, 2006; a004.
39. Jampilek, J.; Dolezal, M.; Osicka, Z.; Kunes, J.; Kralova, K. Substituted pyrazine-2-carboxamides: preparation and their photosynthesis-inhibiting activity. In Proceedings of the 7th International Electronic Conference on Synthetic Organic Chemistry (ECSOC-7), November 1- 30, 2003 [CD-ROM ed.]; Seijas, J.A., Tato, M.P.V., Eds.; MDPI: Basel, Switzerland, 2003; c001.
40. Chlupacova, M.; Opletalova, V.; Kunes, J.; Silva, L.; Buchta, V.; Duskova, L.; Kralova, K. Synthesis and biological evaluation of some ring-substituted (E)-3-aryl-1-pyrazin-2-ylprop-2-en- 1-ones. Folia Pharm. Univ. Carol. 2005, 33, 31-43.
41. Opletalova, V.; Pour, M.; Kunes, J.; Buchta, V.; Silva, L.; Kralova, K.; Chlupacova, M.; Meltrova, D.; Peterka, M.; Poslednikova, M. Synthesis and biological evaluation of (E)-3- (nitrophenyl)-1-(pyrazin-2-yl)prop-2-en-1-ones. Collect. Czech Chem. Commun. 2006, 71, 44-58.
42. Dolezal, M.; Palek, L.; Vinsova, J.; Buchta, V.; Jampilek, J.; Kralova, K. Substituted pyrazinecarboxamides. Synthesis and biological evaluation. Molecules 2006, 11, 242-256.
43. Jampilek, J.; Opletalova, V.; Dolezel, J.; Dohnal, J. Preparation and hydrophobic properties of 5-arylalkylidenerhodanines. In Proceedings of the 11th International Electronic Conference on Synthetic Organic Chemistry (ECSOC-11), November 1-30, 2007 [CD-ROM ed.]; Seijas, J.A., Tato, M.P.V., Eds.; MDPI: Basel, Switzerland, 2003; a012.
44. Kucerova-Chlupacova, M.; Opletalova, V.; Jampilek, J.; Dolezel, J.; Dohnal, J.; Kunes, J.; Pour, M.; Kunes, J.; Vorisek, V. New hydrophobicity constants of substituents in pyrazine rings derived from RP-HPLC Study. Collect. Czech Chem. Comm. 2008, 73, 1-18.
45. Dolezel, J.; Hirsova, P.; Opletalova, V.; Vejsova, M.; Jampilek, J. Synthesis and biological evaluation of rhodanine and N-substituted rhodanine derivatives. Book of Abstracts of the 37th Conference Drug Synthesis and Analysis, Brno, Czech Republic, September 8-10, 2008;.
46. Chem. Listy 2008, 102, S215.
47. Opletalova, V.; Kalinowski, D.; Vejsova, M.; Kunes, J.; Pour, M., Jampilek, J.; Buchta, V.; Richardson, D.R. Identification and characterization of thiosemicarbazones with anti-fungal and anti-tumor effects: Cellular iron-chelation mediating cytotoxic activity. Chem. Res. Toxicol. 2008, 21, 1878-1889.
48. Zhou, J.F.; Song, Y.Z.; Zhu, F.X.; Zhu, Y.L. Facile synthesis of 5-benzylidene rhodanine derivatives under microwave irradiation. Synthetic Commun. 2006, 36, 3297-3303.
49. Sing, W.T.; Lee, C.L.; Yeo, S.L.; Lim, S.P.; Sim, M.M. Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor. Bioorg. Med. Chem. Lett. 2001, 11, 91-94.
50. Khodair, A.I. A convenient synthesis of 2-arylidene-5H-thiazolo[2,3-b] quinazoline-3,5[2H]-diones and their benzoquinazoline derivatives. J. Heterocycl. Chem. 2002, 39, 1153-1160.
51. Ohishi, Y.; Mukai, T.; Nagahara, M.; Yajima, M.; Kajikawa, N.; Miahara, K.; Takano, T. Preparations of 5-alkylmethylidene-3-carboxymethylrhodanine derivatives and their aldose reductase inhibitory activity. Chem. Pharm. Bull. 1990, 38, 1911-1919.
52. Whitessit, C.A.; Simon, R.L.; Reel, J.K.; Sigmund, S.K.; Phillips, M.L.; Shadle, J.K.; Heintz, L.W.; Koppel, G.A.; Hunden, D.C.; Lifer, S.L.; Berry, D.; Ray, J.; Little, S.P.; Liu, X.; Marshall, W.S.; Panetta, J.A. Synthesis and structure-activity relationships of benzophenones as inhibitors of cathepsin D. Bioorg. Med. Chem. Lett. 1996, 6, 2157-2162.
53. Kerns, E.H.; Li, D. Drug-Like Properties: Concept, Structure Design and Methods; Elsevier: San Diego, CA, USA, 2008.
54. Valko, K. Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution. J. Chromatogr. A 2004, 1037, 299-310.
55. 2H). Curr. Med. Chem. 2001, 8, 1137-1146. (Pubitemid 32633663)
56. Cimpan, G.; Irimie, F.; Gocan, S.; Claessens, H.A. Role of stationary phase and eluent composition on the determination of log P values of N-hydroxyethylamide of aryloxyalkylen and pyridine carboxylic acids by reversed-phase high-performance liquid chromatography. J. Chromatogr. B 1998, 714, 247-261.
57. Hartmann, T.; Schmitt, J. Lipophilicity-beyond octanol/water: A short comparison of modern technologies. Drug Discov. Today Technol. 2004, 1, 431-439.
58. Nasal, A.; Siluk, D.; Kaliszan, R. Chromatographic retention parameters in medicinal chemistry and molecular pharmacology. Curr. Med. Chem. 2003, 10, 381-426.
59. Piraprez, G.; Herent, M.F.; Collin, S. Determination of the lipophilicity of aroma compounds by RP-HPLC. Flavour Fragr. J. 1998, 13, 400-408.
60. Yamagami, C.; Iwasaki, K.; Ishikawa, A. Hydrophobicity parameters determined by reversedphase liquid chromatography. XII. Comparison of capacity factors and octane/methanol-water partition coefficients for monosubstituted pyrazines, and effect of octanol added to both partitioning systems. Chem. Pharm. Bull. 1997, 45, 1653-1658.
61. Yamagami, C.; Araki, K.; Ohnishi, K.; Hanasato, K.; Inaba, H.; Aono, M.; Ohta, A. Measurement and prediction of hydrophobicity parameters for highly lipophilic compounds: Application of the HPLC column-switching technique to measurement of log P of diarylpyrazines. J. Pharm. Sci. 1999, 88, 1299-1304.
62. oct by using RP-HPLC procedures. Chem. Pharm. Bull. 2002, 50, 1578-1583.
63. Sortino, M.; Delgado, P.; Juarez, S.; Quiroga, J.; Abonía, R.; Insuasty, B.; Nogueras, M.; Roredo, L.; Garibotto, F. M.; Enriz, R.D.; Zacchino, S. A. Synthesis and antifungal activity of (Z)-5-arylidenerhodanines. Bioorg. Med. Chem. 2007, 15, 484-494.
64. 3-substituted analogues. Book of Abstracts of the 5th International Postgraduate Research Symposium on Pharmaceutics (IPORSIP-2007), Istanbul, September 13-15, 2007. Acta Pharma. Sci. 2007, 49 (Suppl.), 77.